List view / Grid view
The new features in Clampex 11 software enhance functionality in Protocol Editor, increasing the user's ability to create complex experimental protocols involving many command stimulations.
Evaluation of neurotoxicity effects is an active area of investigation in drug discovery and disease modeling.
Hear about the latest Drug Target Review updates from Deputy Editor Victoria Rees who discusses our new report on AI & Informatics, the Cell & Gene Therapy Advancements online summit and much more!
Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
In this short video we show an example of a 3D airway organoid model along with some interesting ways to get the most out of this type of assay.
New podcast on SARS-CoV-2 molecular testing: From human sample analysis to Wastewater Surveillance.
DTR's Victoria Rees interviews Payton Weidenbacher from Stanford University, who discusses a new potential SARS-CoV-2 vaccine that the team he works on developed using nanotechnology.
This webinar from Bio-Techne demonstrates how to use a novel in vitro flow cytometry-based assay to monitor SARS-CoV-2 binding to ACE-2.
This webinar from Bio-Techne discusses canonical and alternative oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence.
Our full gene-to-protein workflow can support your research for rapid protein production early during drug development so you can minimize changes from R&D to bioproduction.
Water immersion objectives are essential for capturing more data at greater depths in 3D structures, such as spheroids and thick tissues.
Explore this virtual tour of the ImageXpress Pico Automated Cell Imaging System from Molecular Devices, including hardware and software.
Explore this virtual tour of the ImageXpress Micro Confocal High-Content Imaging System from Molecular Devices, including hardware and software.
This webinar explains how synthetic guide RNAs are stable, eliminate cloning and sequencing steps, and avoid innate immune responses and cytotoxicity.
HCPs are critical to quality control in biologics development. If left unremoved, they can cause immunogenic responses and reduce drug efficacy.
